Recent studies indicated that tumor expression of COX-2 can lead to epithelial to mesenchymal transition in breast tumor cells [24], and the pharmacological inhibition of COX-2 reduces breast tumor development [25, 26]. The gene discussed is PTGS2; the disease is breast neoplasm.